1. Home
  2. Browse Decisions
  3. F.Supp.3d
  4. 520 F.Supp.3d
  5. 520 F.Supp.3d 514 (2021)
 

NOVARTIS PHARMA AG v. INCYTE CORP.

1:20-cv-00400-GHW.

520 F.Supp.3d 514 (2021)

NOVARTIS PHARMA AG, Plaintiff, v. INCYTE CORPORATION, Defendant.

United States District Court, S.D. New York.

As Amended February 22, 2021.

Attorney(s) appearing for the Case

Sylvia E. Simson , Harold S. Shaftel , Greenberg Traurig, P.A., New York, NY, for Plaintiff.

Daniel Paul Mach , Francis Dominic Cerrito , Richard Irving Werder, Jr. , Quinn Emanuel Urquhart & Sullivan LLP, New York, NY, for Defendant.

MEMORANDUM OPINION AND ORDER

Plaintiff Novartis Pharma AG ("Novartis") and Defendant Incyte Corporation ("Incyte") forged an agreement to work together to commercialize a valuable drug compound called ruxolitinib. Incyte had an innovative concept. Novartis provided financing to kickstart...

Let's get started

Leagle.com

Welcome to the leading source of independent legal reporting
Sign on now to see your case.
Or view more than 10 million decisions and orders.

  • Updated daily.
  • Uncompromising quality.
  • Complete, Accurate, Current.

Listed below are the cases that are cited in this Featured Case. Click the citation to see the full text of the cited case. Citations are also linked in the body of the Featured Case.

Cited Cases

  • No Cases Found

Listed below are those cases in which this Featured Case is cited. Click on the case name to see the full text of the citing case.

Citing Cases